Meredith Rosenthal: AI Safety & Value-Based Care Returns
Value-based care (VBC) models are increasingly reshaping the healthcare landscape, shifting the focus from volume to outcomes. This fundamental change creates a powerful financial incentive…
Value-based care (VBC) models are increasingly reshaping the healthcare landscape, shifting the focus from volume to outcomes. This fundamental change creates a powerful financial incentive…
The landscape of artificial intelligence in healthcare, particularly within the highly regulated domain of cardiology, is a complex interplay of technological innovation and stringent oversight.…
EHR alerts, once hailed as a cornerstone of patient safety and clinical efficiency, have paradoxically become a significant source of clinician burden and, in some…
The proliferation of artificial intelligence in healthcare promises transformative advancements, yet this promise is inextricably linked to a foundational question: can we trust the data…
The proliferation of artificial intelligence in healthcare demands an unwavering commitment to clinical reliability. For Clinical Informaticists and Clinicians navigating this landscape, the critical question…
The promise of artificial intelligence in healthcare is immense, yet the path from innovative concept to reliable clinical tool is fraught with complexities. The stark…
The promise of artificial intelligence in healthcare hinges on its ability to learn and adapt, continuously improving its performance and utility. However, this inherent adaptability…
The proliferation of Artificial Intelligence in healthcare presents an unprecedented opportunity for diagnostic and therapeutic advancements. However, for those charged with patient safety and clinical…
The narrative surrounding artificial intelligence in healthcare often conflates regulatory clearance with guaranteed clinical efficacy and commercial viability. This dangerous oversimplification, particularly for AI-driven Software…
The promise of artificial intelligence in healthcare is immense, yet the chasm between vendor claims and clinically validated impact remains a significant hurdle. For clinical…